Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide for cervical spondylotic radiculopathy
jRCTs041210043Recruiting
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of zonisamide in cervical spondylotic radiculopathy (CSR) (4 arms). Primary endpoints: Incidence of adverse events, Incidence of serious adverse events and 2 more. Started Jan 2022; status: recruiting.
02
Drugs
zonisamide
03
Conditions
cervical spondylotic radiculopathy (CSR)
Beyond the preview
Go deeper on jRCTs041210043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041210043.